Eur Respir J 2002; 19:275-283
Copyright ©ERS Journals Ltd 2002
Clinical significance of histological classification of idiopathic interstitial pneumonia
K.R. Flaherty1,
G.B. Toews1,
W.D. Travis2,
T.V. Colby3,
E.A. Kazerooni4,
B.H. Gross4,
A. Jain5,
R.L. Strawderman, III5,
R. Paine1,
A. Flint6,
J.P. Lynch, III1 and
F.J. Martinez1
1 Division of Pulmonary and Critical Care Medicine and Depts of 4 Radiology and 6 Pathology, University of Michigan Health System, Ann Arbor, MI, 2 Armed Forces Institute of Pathology, Washington DC, 3 Mayo Clinic, Scottsdale, AZ, and 5 Dept of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA
CORRESPONDENCE: F.J. Martinez, Taubman Center 3916, 1500 E. Medical Center Dr. Ann Arbor, MI, 48109-0360, USA. Fax: 1 734 9365048. E-mail: fmartine@umich.edu
Keywords: idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, usual interstitial pneumonia
Received: February 23, 2001
Accepted September 6, 2001
This study was supported in part by National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grant #P50HL46487, NIH/NCRR 3 MO1 RR00042-33S3, NIH/NIA P60 AG08808-06 and NHLBI, 1 K24 HL04212-01.
Patients with idiopathic interstitial pneumonias (IIPs) can be subdivided into groups based on the histological appearance of lung tissue obtained by surgical biopsy. The quantitative impact of histological diagnosis, baseline factors and response to therapy on survival has not been evaluated.
Surgical lung biopsy specimens from 168 patients with suspected IIP were reviewed according to the latest diagnostic criteria. The impact of baseline clinical, physiological, radiographic and histological features on survival was evaluated using Cox regression analysis. The predictive value of honeycombing on high-resolution computed tomography (HRCT) as a surrogate marker for usual interstitial pneumonia (UIP) was examined. The response to therapy and survival of 39 patients treated prospectively with high-dose prednisone was evaluated.
The presence of UIP was the most important factor influencing mortality. The risk ratio of mortality when UIP was present was 28.46 (95% confidence interval (CI) 5.5148.0; p=0.0001) after controlling for patient age, duration of symptoms, radiographic appearance, pulmonary physiology, smoking history and sex. Honeycombing on HRCT indicated the presence of UIP with a sensitivity of 90% and specificity of 86%. Patients with nonspecific interstitial pneumonia were more likely to respond or remain stable (9 of 10) compared to patients with UIP (14 of 29) after treatment with prednisone. Patients remaining stable had the best prognosis. The risk ratio of mortality for stable patients compared to nonresponders was 0.32 (95% CI 0.110.93; p=0.04) in all patients and 0.33 (95% CI 0.120.96; p=0.04) in patients with UIP.
The histological diagnosis of usual interstitial pneumonia is the most important factor determining survival in patients with suspected idiopathic interstitial pneumonia. The presence of honeycombing on high-resolution computed tomography is a good surrogate for usual interstitial pneumonia and could be utilized in patients unable to undergo surgical lung biopsy. Patients with nonspecific interstitial pneumonia are more likely to respond or remain stable following a course of prednisone. Patients remaining stable following prednisone therapy have the best prognosis.
This article has been cited by other articles:

|
 |

|
 |
 
W. D. Travis, T. V. Colby, J. R. Galvin, G. Hunninghake, T. E. King Jr., D. A. Lynch, and The Writing Committee, on Behalf of the ATS Nonspe
Surgical Lung Biopsy in the Diagnosis of Idiopathic NSIP: Do We Always Need It in the Initial Approach?
Am. J. Respir. Crit. Care Med.,
June 1, 2009;
179(11):
1071 - 1072.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ohshimo, F. Bonella, A. Cui, M. Beume, N. Kohno, J. Guzman, and U. Costabel
Significance of Bronchoalveolar Lavage for the Diagnosis of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
June 1, 2009;
179(11):
1043 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Groves, T. Win, N. J. Screaton, M. Berovic, R. Endozo, H. Booth, I. Kayani, L. J. Menezes, J. C. Dickson, and P. J. Ell
Idiopathic Pulmonary Fibrosis and Diffuse Parenchymal Lung Disease: Implications from Initial Experience with 18F-FDG PET/CT
J. Nucl. Med.,
April 1, 2009;
50(4):
538 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Fell, L. X. Liu, C. Motika, E. A. Kazerooni, B. H. Gross, W. D. Travis, T. V. Colby, S. Murray, G. B. Toews, F. J. Martinez, et al.
The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
March 1, 2009;
179(5):
402 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
635 - 686.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. N. Park, Y. Jegal, D. S. Kim, K-H. Do, B. Yoo, T. S. Shim, C-M. Lim, S. D. Lee, Y. Koh, W. S. Kim, et al.
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
Eur. Respir. J.,
January 1, 2009;
33(1):
68 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Kligerman, S. Groshong, K. K Brown, and D. A. Lynch
Nonspecific Interstitial Pneumonia: Radiologic, Clinical, and Pathologic Considerations1
RadioGraphics,
January 1, 2009;
29(1):
73 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sundaram, B. H. Gross, F. J. Martinez, E. Oh, N. L. Muller, M. Schipper, and E. A. Kazerooni
Accuracy of High-Resolution CT in the Diagnosis of Diffuse Lung Disease: Effect of Predominance and Distribution of Findings
Am. J. Roentgenol.,
October 1, 2008;
191(4):
1032 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Arakawa, K. Fujimoto, K. Honma, N. Suganuma, H. Morikubo, Y. Saito, H. Shida, and Y. Kaji
Progression from Near-Normal to End-Stage Lungs in Chronic Interstitial Pneumonia Related to Silica Exposure: Long-Term CT Observations
Am. J. Roentgenol.,
October 1, 2008;
191(4):
1040 - 1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Shin, K. S. Lee, M. P. Chung, J. Han, Y. A Bae, T. S. Kim, and M. J. Chung
Prognostic Determinants among Clinical, Thin-Section CT, and Histopathologic Findings for Fibrotic Idiopathic Interstitial Pneumonias: Tertiary Hospital Study
Radiology,
October 1, 2008;
249(1):
328 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax,
September 1, 2008;
63(Suppl_5):
v1 - v58.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. D. Travis, G. Hunninghake, T. E. King Jr., D. A. Lynch, T. V. Colby, J. R. Galvin, K. K. Brown, M. P. Chung, J.-F. Cordier, R. M. du Bois, et al.
Idiopathic Nonspecific Interstitial Pneumonia: Report of an American Thoracic Society Project
Am. J. Respir. Crit. Care Med.,
June 15, 2008;
177(12):
1338 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Han, S. Murray, C. D. Fell, K. R. Flaherty, G. B. Toews, J. Myers, T. V. Colby, W. D. Travis, E. A. Kazerooni, B. H. Gross, et al.
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Eur. Respir. J.,
June 1, 2008;
31(6):
1183 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thomeer, M. Demedts, J. Behr, R. Buhl, U. Costabel, C. D. R. Flower, J. Verschakelen, F. Laurent, A. G. Nicholson, E. K. Verbeken, et al.
Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis
Eur. Respir. J.,
March 1, 2008;
31(3):
585 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Huang, S. H. Wettlaufer, C. M. Hogaboam, K. R. Flaherty, F. J. Martinez, J. L. Myers, T. V. Colby, W. D. Travis, G. B. Toews, and M. Peters-Golden
Variable Prostaglandin E2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
January 1, 2008;
177(1):
66 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Noth and F. J. Martinez
Recent Advances in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2007;
132(2):
637 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B Gotway, M. M Freemer, and T. E King Jr
Challenges in pulmonary fibrosis {middle dot} 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias
Thorax,
June 1, 2007;
62(6):
546 - 553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, A.-C. Andrei, T. E. King Jr., G. Raghu, T. V. Colby, A. Wells, N. Bassily, K. Brown, R. du Bois, A. Flint, et al.
Idiopathic Interstitial Pneumonia: Do Community and Academic Physicians Agree on Diagnosis?
Am. J. Respir. Crit. Care Med.,
May 15, 2007;
175(10):
1054 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M Rudd, R. J Prescott, J C Chalmers, I. D A Johnston, and for the Fibrosing Alveolitis Subcommittee of the R
British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival
Thorax,
January 1, 2007;
62(1):
62 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu, D. Weycker, J. Edelsberg, W. Z. Bradford, and G. Oster
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
October 1, 2006;
174(7):
810 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, A.-C. Andrei, S. Murray, C. Fraley, T. V. Colby, W. D. Travis, V. Lama, E. A. Kazerooni, B. H. Gross, G. B. Toews, et al.
Idiopathic Pulmonary Fibrosis: Prognostic Value of Changes in Physiology and Six-Minute-Walk Test
Am. J. Respir. Crit. Care Med.,
October 1, 2006;
174(7):
803 - 809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Thannickal and A. U. Wells
Classification of Interstitial Pneumonias: What Do Gene Expression Profiles Tell Us?
Am. J. Respir. Crit. Care Med.,
January 15, 2006;
173(2):
141 - 142.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS,
January 1, 2006;
3(1):
81 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Misumi and D. A. Lynch
Idiopathic pulmonary fibrosis/usual interstitial pneumonia: imaging diagnosis, spectrum of abnormalities, and temporal progression.
Proceedings of the ATS,
January 1, 2006;
3(4):
307 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and K. Flaherty
Pulmonary function testing in idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
315 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Visscher and J. L. Myers
Histologic spectrum of idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
322 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A Pacanowski and G. W Amsden
Interferon Gamma-1b in the Treatment of Idiopathic Pulmonary Fibrosis
Ann. Pharmacother.,
October 1, 2005;
39(10):
1678 - 1686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Kinnula, C. L. Fattman, R. J. Tan, and T. D. Oury
Oxidative Stress in Pulmonary Fibrosis: A Possible Role for Redox Modulatory Therapy
Am. J. Respir. Crit. Care Med.,
August 15, 2005;
172(4):
417 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ito, S. Nagai, M. Kitaichi, A. G. Nicholson, T. Johkoh, S. Noma, D. S. Kim, T. Handa, T. Izumi, and M. Mishima
Pulmonary Manifestations of Primary Sjogren's Syndrome: A Clinical, Radiologic, and Pathologic Study
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
632 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Nadrous, J. L. Myers, P. A. Decker, and J. H. Ryu
Idiopathic Pulmonary Fibrosis in Patients Younger Than 50 Years
Mayo Clin. Proc.,
January 1, 2005;
80(1):
37 - 40.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, T. E. King Jr., G. Raghu, J. P. Lynch III, T. V. Colby, W. D. Travis, B. H. Gross, E. A. Kazerooni, G. B. Toews, Q. Long, et al.
Idiopathic Interstitial Pneumonia: What Is the Effect of a Multidisciplinary Approach to Diagnosis?
Am. J. Respir. Crit. Care Med.,
October 15, 2004;
170(8):
904 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Khalil and R. O'Connor
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
Can. Med. Assoc. J.,
July 20, 2004;
171(2):
153 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A G Nicholson, B J Addis, H Bharucha, C A Clelland, B Corrin, A R Gibbs, P S Hasleton, K M Kerr, N B N Ibrahim, S Stewart, et al.
Inter-observer variation between pathologists in diffuse parenchymal lung disease
Thorax,
June 1, 2004;
59(6):
500 - 505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Jakubzick, E S Choi, S L Kunkel, H Evanoff, F J Martinez, R K Puri, K R Flaherty, G B Toews, T V Colby, E A Kazerooni, et al.
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia
J. Clin. Pathol.,
May 1, 2004;
57(5):
477 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Monaghan, A. U. Wells, T. V. Colby, R. M. du Bois, D. M. Hansell, and A. G. Nicholson
Prognostic Implications of Histologic Patterns in Multiple Surgical Lung Biopsies From Patients With Idiopathic Interstitial Pneumonias
Chest,
February 1, 2004;
125(2):
522 - 526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Costabel
Idiopathic pulmonary fibrosis: a treatable disease?
Eur. Respir. J.,
December 1, 2003;
22(6):
872 - 873.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. N. Lama, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, Q. Long, S. Murray, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al.
Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
November 1, 2003;
168(9):
1084 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al.
Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol.,
September 1, 2003;
29(3):
S1 - 105.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, J. A. Mumford, S. Murray, E. A. Kazerooni, B. H. Gross, T. V. Colby, W. D. Travis, A. Flint, G. B. Toews, J. P. Lynch III, et al.
Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
September 1, 2003;
168(5):
543 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Meyer
Interferon Gamma-1b Therapy for Idiopathic Pulmonary Fibrosis: Is the Cart Before the Horse?
Mayo Clin. Proc.,
September 1, 2003;
78(9):
1073 - 1075.
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, T. V. Colby, W. D. Travis, G. B. Toews, J. Mumford, S. Murray, V. J. Thannickal, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al.
Fibroblastic Foci in Usual Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease
Am. J. Respir. Crit. Care Med.,
May 15, 2003;
167(10):
1410 - 1415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. King Jr.
Nonspecific Interstitial Pneumonia and Systemic Sclerosis
Am. J. Respir. Crit. Care Med.,
June 15, 2002;
165(12):
1578 - 1579.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the European Respiratory Society.
|